Skip to main content
PMC home page
Gut logoLink to Gut
. 1994 Apr;35(4):467–470. doi: 10.1136/gut.35.4.467

Symptom relief and quality of life after stenting for malignant bile duct obstruction.

A B Ballinger 1, M McHugh 1, S M Catnach 1, E M Alstead 1, M L Clark 1
PMCID: PMC1374793  PMID: 7513672

Abstract

Palliative treatment is appropriate for most patients with cancer of the head of pancreas. Insertion of a biliary stent relieves jaundice and pruritus but it is not known if stenting affects other symptoms or changes the quality of life. Nineteen patients have completed a standard questionnaire to assess symptom relief and quality of life after stent insertion. After stenting there was complete relief of jaundice and pruritus. Furthermore, there was also considerable improvement in anorexia and indigestion. All patients had anorexia before stent insertion, this was moderate/severe in 13 (68.4%). Anorexia was significantly better (p < 0.01) a week after stenting and this benefit was maintained at 12 weeks (p < 0.01). Sixteen (84.2%) patients complained of indigestion before stenting, moderate/severe in 11 (57.9%). This was significantly better (p < 0.01) a week after stenting with complete relief in six at eight weeks (p < 0.01). Fifteen (78.9%) felt that their mood was good/very good before stent insertion and this was unchanged even at the 12 week assessment. A similar result was obtained for physical health and level of activity. In conclusion stent insertion not only relieves jaundice and pruritus in these patients but also improves other symptoms and quality of life. The considerable improvement in appetite after stenting was of particular benefit.

Full text

PDF
467

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen J. R., Sørensen S. M., Kruse A., Rokkjaer M., Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut. 1989 Aug;30(8):1132–1135. doi: 10.1136/gut.30.8.1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arbuck S. G. Overview of chemotherapy for pancreatic cancer. Int J Pancreatol. 1990 Aug-Nov;7(1-3):209–222. doi: 10.1007/BF02924239. [DOI] [PubMed] [Google Scholar]
  3. Balkwill F., Osborne R., Burke F., Naylor S., Talbot D., Durbin H., Tavernier J., Fiers W. Evidence for tumour necrosis factor/cachectin production in cancer. Lancet. 1987 Nov 28;2(8570):1229–1232. doi: 10.1016/s0140-6736(87)91850-2. [DOI] [PubMed] [Google Scholar]
  4. Bemelmans M. H., Gouma D. J., Greve J. W., Buurman W. A. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology. 1992 Jun;15(6):1132–1136. doi: 10.1002/hep.1840150626. [DOI] [PubMed] [Google Scholar]
  5. Canova A., Geary N. Intraperitoneal injections of nanogram CCK-8 doses inhibit feeding in rats. Appetite. 1991 Dec;17(3):221–227. doi: 10.1016/0195-6663(91)90024-m. [DOI] [PubMed] [Google Scholar]
  6. Connolly M. M., Dawson P. J., Michelassi F., Moossa A. R., Lowenstein F. Survival in 1001 patients with carcinoma of the pancreas. Ann Surg. 1987 Sep;206(3):366–373. doi: 10.1097/00000658-198709000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Crown J., Casper E. S., Botet J., Murray P., Kelsen D. P. Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma. J Clin Oncol. 1991 Sep;9(9):1682–1686. doi: 10.1200/JCO.1991.9.9.1682. [DOI] [PubMed] [Google Scholar]
  8. Diamond T., Dolan S., Thompson R. L., Rowlands B. J. Development and reversal of endotoxemia and endotoxin-related death in obstructive jaundice. Surgery. 1990 Aug;108(2):370–375. [PubMed] [Google Scholar]
  9. Hellerstein M. K., Meydani S. N., Meydani M., Wu K., Dinarello C. A. Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. J Clin Invest. 1989 Jul;84(1):228–235. doi: 10.1172/JCI114145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hill A. J., Peikin S. R., Ryan C. A., Blundell J. E. Oral administration of proteinase inhibitor II from potatoes reduces energy intake in man. Physiol Behav. 1990 Aug;48(2):241–246. doi: 10.1016/0031-9384(90)90307-p. [DOI] [PubMed] [Google Scholar]
  11. Huddart R. A., Hubbard C. S., Dickinson R. J. Biliary stenting for malignant jaundice. A district hospital experience. Clin Radiol. 1991 Feb;43(2):103–106. doi: 10.1016/s0009-9260(05)81587-9. [DOI] [PubMed] [Google Scholar]
  12. Liddle R. A., Goldfine I. D., Rosen M. S., Taplitz R. A., Williams J. A. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest. 1985 Apr;75(4):1144–1152. doi: 10.1172/JCI111809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nakamura R., Miyasaka K., Kuyama Y., Kitani K. Luminal bile regulates cholecystokinin release in conscious rats. Dig Dis Sci. 1990 Jan;35(1):55–60. doi: 10.1007/BF01537223. [DOI] [PubMed] [Google Scholar]
  14. Oliff A., Defeo-Jones D., Boyer M., Martinez D., Kiefer D., Vuocolo G., Wolfe A., Socher S. H. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 1987 Aug 14;50(4):555–563. doi: 10.1016/0092-8674(87)90028-6. [DOI] [PubMed] [Google Scholar]
  15. Owyang C., May D., Louie D. S. Trypsin suppression of pancreatic enzyme secretion. Differential effect on cholecystokinin release and the enteropancreatic reflex. Gastroenterology. 1986 Sep;91(3):637–643. doi: 10.1016/0016-5085(86)90633-5. [DOI] [PubMed] [Google Scholar]
  16. Ozaki H., Hojo K., Kato H., Kinoshita T., Egawa S., Kishi K. Multidisciplinary treatment for resectable pancreatic cancer. Int J Pancreatol. 1988 May;3(4):249–259. doi: 10.1007/BF02788454. [DOI] [PubMed] [Google Scholar]
  17. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]
  18. de Haes J. C., van Knippenberg F. C., Neijt J. P. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990 Dec;62(6):1034–1038. doi: 10.1038/bjc.1990.434. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES